Logo

And Adding to Our Confidence Levels...

Nov 18, 2008

The US House Committee on Energy and Commerce will be investigating accusations made by eight FDA scientists against the agency, reports the New York Times. The scientists say that managers at the agency have "corrupted the scientific review of medical devices" and have had devices approved when the data is ambiguous. "These allegations are deeply concerning and we intend to uncover whether any FDA activity has compromised the health and safety of American consumers," committee chair John Dingell (D-MI) says.

Breaking News
The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.